Opioid overdose deaths in Oregon dropped for the second consecutive year, offering a fragile but meaningful sign of progress in one of the hardest-hit states of the fentanyl crisis. However, health experts warn the epidemic is far from over.

Oregon enjoys a wide variety of grassroots programs and support groups like Narcotics Anonymous that have helped drive those numbers down. The Beaver State also features many inpatient and outpatient services. The results show: the state reported 1,015 confirmed or suspected opioid overdose deaths in the 12 months prior to August 2025, down from 1,272 deaths the previous year and a decline of nearly 20%. 

Opioid Overdose Numbers in Oregon

The drop marks more than 30% below Oregon’s peak recorded in May 2024. But context is critical: Oregon’s opioid death rate remains almost 3x that of May 2020, when 351 people died from overdoses. 

Dr. Todd Korthuis heads the department of addiction medicine at Oregon Health & Science University. He urged continued vigilance as people are still dying at higher rates than a decade ago. “This is progress,” Korthuis noted, “but we’re not out of the woods.” 

Fatal overdoses account for only a fraction of the numbers. Oregon had close to 4,200 inpatient hospitalizations associated with drug overdose and 10,300+ overdose-related emergency department visits in 2024 alone. These figures are actually much higher because they exclude overdoses that were reversed with naloxone.

Driving the Decline in Opioid Deaths

Health experts point to several overlapping factors behind the downward trend.

• Supply disruption: The most significant contributor is disruption in the illicit fentanyl supply chain, beginning with a crackdown on manufacturers in China. Researchers link this disruption to weaker fentanyl potencies reaching the market, resulting in fewer overdoses. 

• Expanded treatment access: Korthuis credited wider availability of medication-assisted treatments, including buprenorphine and methadone. Methadone has become a popular option for people seeking relief from fentanyl withdrawal. 

• Naloxone distribution: Oregon’s Save Lives Oregon program, run by the Oregon Health Authority, now distributes naloxone to 380+ organizations statewide for emergency departments, health care settings and school-based clinics. 

Fentanyl Remains the Dominant Threat

Most Oregon deaths involved fentanyl, often in combination with methamphetamine. For anyone with an opioid addiction or watching a loved one fight it, the numbers represent both hard-won progress and the ongoing weight of this crisis.

Because of fentanyl’s extreme potency and low production cost, it is frequently mixed into counterfeit pills or combined with heroin, methamphetamine, and cocaine in unknown amounts. These combos dramatically increase overdose risk for users.

Korthuis emphasized the fragility of current gains: “It could turn on a dime, and those same factors that seem to be contributing to declines in overdoses could reverse.” He called for sustained support for naloxone distribution and evidence-based prevention targeting young people before exposure to opioids occurs.

As Korthuis explained, progress has been uneven among certain groups. Communities of color that have disproportionately faced systemic racism and socioeconomic inequity continue to experience the highest rates of both fatal and nonfatal opioid overdoses in Oregon. Any sustainable response to the opioid crisis must address these underlying disparities.

Harm Reduction and Treatment Options in Oregon

Oregon’s declining overdose numbers reflect coordinated harm reduction and treatment efforts that often start at the ground up. Peer support and NA meetings provide free, community-based peer recovery support for people dealing with narcotic addiction. They occur daily and in cities big and small.
To get started, feel free to call 800-934-1582(Sponsored) or glance through our comprehensive directory of NA groups today.

A recent clinical trial has produced the strongest evidence yet that a common generic antidepressant can help reduce methamphetamine use. This is a significant development in narcotic addiction treatment as no FDA-approved medication currently exists for the disorder.

An impressive array of programs and services already addresses many facets of addiction, from grassroots Narcotics Anonymous peer support groups to inpatient care. However, these new findings offer a potential foothold in treating stimulant use disorder without a single approved pharmacological option.

The Opioid Crisis & the Broader Narcotics Epidemic

While fentanyl and opioid addiction have dominated public health headlines for over a decade, methamphetamine use has surged in parallel. Indeed, the two even overlap as illicit drug markets regularly involve polysubstance use. Deaths involving both methamphetamine and synthetic opioids like fentanyl have become alarmingly common in overdose data.

Yet unlike available medication assisted treatment for opioid addictions, methamphetamine use disorder has had no equivalent. Instead, providers have opted for psychosocial counseling, behavioral therapy and peer support. These approaches are effective, but limited.

The Mirtazapine Trial’s Findings

That’s where this new study comes in. From November 2022 to May 2025, six outpatient alcohol and drug clinics in Australia enrolled 339 adults with moderate to severe methamphetamine use disorder. These participants had used methamphetamine for around 24 days out of a month.

Led by Dr. Rebecca McKetin of the National Drug and Alcohol Research Centre at the University of New South Wales Sydney, the team learned that those who took mirtazapine stayed off meth for around 7 days, two days longer when compared to those who took the placebo.

“The exciting thing about our finding is that we’re able to confirm that mirtazapine, this generic antidepressant that’s widely available and quite cheap, can actually help people to reduce their methamphetamine use,” McKetin noted, adding that the drug has a “well-established safety profile.”

Narcotic Addiction Treatment & the FDA Approval Gap

Mirtazapine is already approved as an antidepressant and widely available as a low-cost generic. The medication addresses a key driver of relapse. Patients who attempt to quit methamphetamine often face severe mood swings, depression, and insomnia that push them back toward use and discourage them from trying to quit again. Mirtazapine’s sedating and mood-stabilizing properties may blunt those withdrawal symptoms enough to interrupt the cycle.

“At the moment, all of the treatment options we’ve got are psychosocial, and can be difficult to access,” McKetin noted. For general practitioners, she said, they can use mirtazapine “to help people who want to reduce their methamphetamine use, in addition to using it for depression, and they can do that fairly safely.”

Important Limitations

The trial’s authors were candid about the modest scope of the effect. McKetin acknowledged it showed “quite a small effect” on methamphetamine use, and noted that secondary depression, insomnia, HIV risk behavior, and quality of life showed no significant improvement.

Treatment effects were also impacted by side effects. Almost 25% of the mirtazapine participants stopped taking the drug due to side effects, compared to 15% on placebo. The most common adverse effects were drowsiness and weight gain.

“As researchers, we need to come up with something that has a stronger impact and a larger treatment effect,” McKetin observed.

What This Means for People in Recovery

For individuals navigating narcotic addiction, this research underscores how recovery is a medical process, not a moral failure, and the science of treating it continues to evolve. The most durable recoveries typically combine pharmacological support with peer connection, behavioral therapy, and community.

Narcotics Anonymous meetings offer exactly that kind of sustained peer support. Meetings are free, accessible, and available every day. For anyone with methamphetamine or opioid addiction, NA meetings provide a space to build the human connections that make long-term recovery possible.

To find an NA meeting near your location, take a look through our directory or call 800-934-1582(Sponsored) to get started and to explore options for recovery.

Milwaukee County recorded 383 opioid overdose deaths in 2025, the lowest annual total in a decade. It’s a rare and hard-won sign of progress in a city that lost nearly 5,000 people to the overdose epidemic between 2017 and 2025. What changed isn’t a mystery: a small team of firefighters, peer support specialists, and community partners decided to do things differently.

America’s Dairyland features a wide range of programs to battle opioid overdose, and for many residents in Milwaukee, hope often starts with community members and families. And that’s where change started from the ground up.

Milwaukee’s Opioid Crisis by the Numbers

The 383 fatal overdoses in 2025 represent Milwaukee County’s lowest number since 2016. That figure marks a dramatic reversal from the epidemic’s peak. From 2017 to 2025, nearly 4,600 people died due to drug overdoses across Milwaukee County. In 2022 alone, the county witnessed 674 fatal overdose deaths, fueled by widespread opioids, heroin, and other substances with fentanyl. 

But then the numbers took an abrupt course. Fatality rates fell 30% in 2024, followed by a sharp  drop in 2025, about a 50% decline over three years. Milwaukee’s decrease mirrors a nationwide trend tied to expanded treatment access, increased harm reduction efforts, and a shrinking fentanyl supply chain. 

What’s Driving the Change in Opioid Addiction Deaths

The centerpiece of Milwaukee’s turnaround is the Milwaukee Overdose Response Initiative (MORI), a program built from scratch inside the city’s fire department. The team began by using the fire department’s access to 911 call data to identify people who survived an overdose within the last 24 to 48 hours, then went out to find those people and offer whatever help they needed.

That help was deliberately broad. “Help” didn’t necessarily mean pressuring someone into rehab, although the team connected people with treatment programs. It could mean getting someone clothes, food, naloxone and other harm reduction supplies, along with compassionate and nonjudgmental support.

The model was intentionally personal. Team members sat down for conversations, not interrogations. They dropped off birthday cupcakes at homeless encampments, gave people rides to psychiatric appointments, and helped families process the loss of loved ones. 

Peer support specialist Amy Molinski, who joined the team through a medication-assisted treatment clinic, brought her own recovery experience to the work. Her presence helped overdose survivors feel met with dignity rather than shame. “When overdose survivors get greeted by someone in a uniform that doesn’t judge them, tries to take the shame out of what they’re doing and say ‘your life is worth saving’ — that means a lot,” Molinski noted.

Battling Fentanyl

Fentanyl, the synthetic opioid now found contaminating virtually every street drug supply, drove the surge that killed hundreds of Milwaukeeans annually at the height of the crisis. Its extreme potency—roughly 50-100x stronger than morphine—means that even a small, invisible quantity mixed into other drugs can cause a fatal overdose in seconds. Fentanyl is the leading driver of opioid overdose deaths nationally and locally.

Wisconsin legalized fentanyl and xylazine test strips, allowing people to check drugs for dangerous substances before use. This harm reduction measure is credited as a meaningful intervention. Knowing what’s in a substance doesn’t eliminate risk, but it can save a life.

Also on the front lines against opioids is Narcan, the nasal spray medication used to reverse an opioid overdose. It’s now found in Milwaukee bars, stores, and other public spaces, usually through free vending machines. Fire Lt. Jonathan Belott, MORI’s project manager, put it plainly: “Keep that Narcan flowing out there.”

The Milwaukee Overdose Response Initiative distributes “Hope Kits”—small pouches stocked with Narcan, fentanyl and xylazine test strips, and contact information for treatment centers, therapy, and groups like Narcotics Anonymous and Alcoholics Anonymous. Every single frontline firefighter is equipped with Hope Kits.

Peer Recovery and Finding Help for Opioid Addiction

Milwaukee’s model worked in part because it paired clinical resources with lived experience. Molinski, who battled her own heroin addiction before entering the peer support field, described how disconnection led her in; connection and hope brought her out. “My life was worth saving,” she recalled.

That message is exactly what Narcotics Anonymous meeting communities offer: spaces where people who have experienced narcotic addiction firsthand can share recovery with those still in its grip. NA meetings across Wisconsin are free, open to all, and require no commitment beyond showing up.
Narcotics Anonymous holds meetings throughout the Milwaukee metro area and throughout the entire state. To find a meeting near you, browse our comprehensive directory or call 800-934-1582(Sponsored) today.

Opioid overdose deaths in the United States have fallen by nearly half since their peak in mid-2023. The drop represents the most significant reduction in the modern history of the opioid epidemic. For the millions of Americans living with narcotic addiction, or loving someone who does, the numbers demonstrate genuine, measurable progress.

Data totaled 46,066 opioid overdose deaths in the 12-month period ending in October 2025. The figure is barely more than half the peak of 86,075 recorded in June 2023 and the lowest total since April 2017. That 2023 peak was the deadliest moment in a fentanyl-driven crisis that devastated communities, overwhelmed emergency rooms, and upended families across the country.

The Opioid Crisis by the Numbers

The decline in opioid overdose deaths has been broad across racial and demographic groups. It’s a notable shift from earlier in the epidemic. Between 2019 and 2023, overdose rates had dropped only among white Americans while rising sharply among Black and Indigenous communities. The new CDC data shows declines across all groups.

Even older Americans, whose overdose fatality numbers had recently surged, saw an overall 25% decline.

Death rates had the steepest drops in West Virginia, Virginia and Florida. Deaths in Ohio dropped over 60%, from 4,300 in 2023 to 1,600 two years later. Not all states benefited, however, as Alaska, Arizona and Nevada had increased opioid overdose deaths.

What is Driving the Drop in Fentanyl Deaths

Experts point to a disruption in the fentanyl supply chain as the most likely primary driver. A crackdown in China on materials used to manufacture illicit fentanyl coincided closely when U.S. deaths began declining in 2023. This supply disruption, and not enhanced U.S. border enforcement or other interdiction efforts, is the most probable explanation for the decline.

The Drug Enforcement Administration reported that close to 30% of the pills seized in 2025 contained lethal doses of fentanyl, down from over 75% in 2023. The DEA attributed this directly to reduced potency and purity in the illicit supply that correlate directly with fewer synthetic opioid deaths.

Stanford University health policy professor Keith Humphreys and a team of researchers agreed. They identified a measurable fentanyl “drought” on social media channels like Reddit at nearly the same time overdose deaths started to fall. The researchers believed that China’s greater scrutiny of precursor chemical production and removal of online advertisements and several chemical marketplaces were likely the reason behind the fentanyl drought and saved lives. 

Fentanyl Supply Changes & New Dangers

The weakening fentanyl supply isn’t without serious complications. In Ohio, people with fentanyl addiction have increasingly turned to pills spiked with animal tranquilizers or so-called “z-drugs” that cause severe addiction. The concoction is so powerful that traditional detox protocols have struggled to manage them. 

RecoveryOhio director Erin Reed oversees the state’s efforts to reduce overdose deaths. Reed described the broader positive trends while acknowledging the changing landscape on the ground. Reed noted reductions in emergency room visits alongside violent crime rates and recidivism.

But the drop is fragile and maybe temporary. Humphreys and his co-authors wrote that demand for fentanyl remains strong, even as the supply chain slows. Humphreys asserted that officials can take the opportunity “to ramp up the prevention and treatment programs that have evidence of decreasing demand.”

Finding Help for Opioid Addiction

Even when people aren’t ready for treatment, that kindness builds trust and can reduce theft and criminal activity that leads to arrests. Others stand ready to assist with overdose medications such as naloxone and other self-harm reduction training.

This peer-driven, compassionate outreach model is central to what Narcotics Anonymous and similar recovery communities provide. NA meetings offer the same consistency and human connection at no cost, with no referral required.
If you or someone you love is fighting narcotic addiction, support is available right now. Call 800-934-1582(Sponsored) or look through our directory to find a support group or local NA meeting today.

A Chattanooga nonprofit is placing a free naloxone dispenser in Miller Park, one of the city’s most-visited public spaces. It’s a direct effort to put life-saving opioid overdose reversal medication in the hands of people who need it most. 

North Carolina boasts plenty of programs to battle opioid addiction no matter where you’re located in the Tar Heel State. But for family members who fear getting that call, a naloxone dispenser can mean the difference between life and death.

The Opioid Crisis in Chattanooga by the Numbers

The numbers behind this initiative are impossible to ignore. One recent study found that naloxone prevented at least 2,400 overdoses around Chattanooga in 2023 alone. That figure reflects both the depth of opioid addiction afflicting Tennesseans and the proven power of naloxone as a frontline intervention. The surrounding region around Hamilton County and the greater Chattanooga area have consistently ranked among the state’s harder-hit regions for opioid-related harm.

What Launch Pad Does and Why It Matters

Launch Pad is a sober living program nonprofit that received a county grant to fund a newspaper-style dispenser box stocked with free naloxone for those who can’t afford Narcan. The box will hold at least 10 packages at all times and sit in a shaded corner of Miller Plaza. The Chattanooga City Council unanimously approved the proposal. 

Launch Pad’s clinical director, Kelli Cruse, acknowledged that supplies will likely go fast at first, but that’s exactly the point. “We want this medication out to the people who are going to use it,” Cruse noted, adding that once people realize that it will be a permanent fixture, they’ll only take what they need.

As for concerns about potential misuse and side effects, Launch Pad leadership noted that the pros of saving lives outweigh any cons. “The risk of not having it is greater than the risk of having it and it being in the wrong hands,” Cruse pointed out. 

Fentanyl’s Role in the Overdose Emergency

The need for naloxone is great. Fentanyl is now the primary driver of opioid overdose deaths in all age groups, and naloxone has proven effective in countering overdoses. According to the CDC, nasal spray or injectable naloxone blocks the effects of opioids and restarts normal breathing in unresponsive overdose victims.

Furthermore, the medication has no effect on a person who does not have opioids in their system. Naloxone’s nontoxicity makes it safe for bystanders, family members, and first responders to carry and use without fear of causing harm.

A Growing Trend Across Tennessee and the U.S.

Chattanooga isn’t alone in this approach. Naloxone dispensers and kiosks have become popular devices in Nashville, Knoxville and other cities for their practicality, including in music venues and bars as part of first aid response.

Public health agencies and nonprofit partners across the country are deploying dispensers. Cities in California, Kentucky, and Iowa have made naloxone available in public spaces such as train stations and college campuses. The number has exploded from an estimated 80 nationwide in 2022 to hundreds today.

Harm Reduction and Opioid Treatment Options in Chattanooga

Remember that naloxone is a bridge, not a treatment for opioid addiction itself. For those struggling with opioid addiction in the Chattanooga area, several pathways to recovery exist alongside harm reduction tools like this dispenser. Even something as basic as attending a Narcotics Anonymous class can connect you with peers who understand your condition.
If you or someone you love is at risk of opioid addiction or an overdose, browse our directory for a nearby support group that fits your needs or call 800-934-1582(Sponsored) to start the battle against narcotics in your life.

Washington state’s Native communities are confronting a fentanyl and opioid addiction crisis with one of the most reliable life-saving tools available, naloxone.

Overdose death rates among American Indian and Alaska Native populations continue to outpace every other demographic in the United States.

Expanded access to the overdose-reversing medication is offering a critical line of defense while tribal leaders push for deeper, culturally grounded treatment solutions.

The Opioid Crisis by the Numbers

The scope of opioid addiction among Native populations is staggering. The American Indian and Alaska Native population has the highest drug overdose death rates in the country.

Statistics show a 33% increase in drug overdose deaths recorded between 2020 and 2021, according to the Centers for Disease Control and Prevention.

Washington state reflects these national trends with alarming clarity. Roughly 65% of all drug deaths in Washington involved synthetic opioids, primarily fentanyl, totaling more than 1,700 deaths in a single year, according to the University of Washington’s Addictions, Drug and Alcohol Institute.

Last year also marked King County’s deadliest year ever for fatal overdoses, with more than 700 involving fentanyl. The human cost inside tribal communities has been devastating.

Lummi Nation Chair Tony Hillaire spoke at the Washington State Tribal Opioid/Fentanyl Summit about the losses his community has endured.

He noting that five members died of fentanyl overdoses in just one week, a crisis severe enough that Lummi leaders declared a state of emergency. “We don’t want to normalize the burying of our children,” Hillaire said.

Fentanyl’s Role in the Native Community Crisis

Fentanyl, a synthetic opioid roughly 50 times more potent than heroin, has proven a particularly difficult threat for tribal communities to address, straining existing clinics and treatment options across Washington and in some cases creating long waitlists for care.

The roots of opioid addiction in Native communities run deep. Indigenous families have confronted substance use disorders for decades as a downstream consequence of centuries of violence, forced family separation, boarding school trauma and the deliberate destruction of tribal economies.

All factors that increase vulnerability to addiction. Poverty, housing insecurity and chronic underinvestment in tribal health infrastructure have compounded that vulnerability as fentanyl moved in. If you or loved one need support with narcotics addiction recovery, you can explore numerous NA meetings in Washington.

Naloxone Distribution Reaches Native Communities

Washington’s state health agencies have moved aggressively to get naloxone, the medication that reverses opioid overdoses, into the hands of people most at risk.

In fiscal year 2025 alone, Washington’s Overdose Education and Naloxone Distribution (OEND) program and its partners distributed approximately 365,306 naloxone kits and held 76 training events reaching more than 1,500 individuals.

Critically, the state’s mail-order naloxone program has proven especially effective at reaching Native populations.

American Indian and Alaska Native community members are more likely to receive naloxone through the mail-order program than through other distribution channels.

Tribes, tribal organizations and Urban Indian Organizations can also request naloxone directly through a dedicated Tribal Naloxone Request Form administered by the Washington State Department of Health.

Still, advocates are clear that naloxone alone cannot solve the opioid addiction crisis. As one addiction specialist at UW Medicine put it, naloxone reverses an overdose for only 30 to 90 minutes, it is a critical intervention, but treatment, support and destigmatization must follow.

What’s Driving the Push for Culturally Grounded Treatment

Tribal health providers in Washington have long argued that opioid addiction treatment works best when it integrates Indigenous cultural traditions alongside Western medicine.

Organizations like the Seattle Indian Health Board use a model called Indigenous Knowledge Informed Systems of Care, blending modern treatment protocols with traditional practices and culturally attuned care, an approach that has produced meaningful results even in the fentanyl era.

Tribal leaders, health providers and state officials broadly agree that more funding is needed, particularly in Native communities, to staff health care centers, open more inpatient beds, expand medication-assisted treatment centers and ensure wider access to naloxone.

At the federal level, the National Institutes of Health has taken notice. NIH launched a dedicated program to advance substance use research led by Native American communities, with a second phase of expanded capacity-building research anticipated to begin in fall 2026.

Understanding Opioid Addiction and Naloxone

Opioid addiction is a chronic, relapsing medical condition driven by dependence on substances such as heroin, fentanyl, prescription painkillers like oxycodone and methadone.

Fentanyl, now the dominant driver of overdose deaths nationally, is particularly dangerous because it is often mixed into counterfeit pills and other substances without the user’s knowledge, making every use a potential overdose risk.

Naloxone (brand name Narcan) is an FDA-approved medication that rapidly reverses opioid overdose when administered as a nasal spray or injection, and is available without a prescription in Washington state.

Opioid Addiction Treatment Options

For anyone struggling with opioid addiction, multiple treatment options exist. Narcotics.com provides a directory of NA meetings, including in and near tribal communities. You can also call 800-934-1582(Sponsored) to receive additional support today.

For anyone touched by opioid addiction, whether personally or through someone they love, the statistics are both heartbreaking and familiar.

Too many pain journeys end not in recovery, but in dependence, overdose or death. Now, a wave of new treatments and federal policy shifts are aiming to break that cycle before it begins.

The Opioid Crisis by the Numbers

Overdose deaths remain staggering. According to the CDC, roughly 79,384 people died from drug overdoses in 2024, a 26.2% drop from the more than 110,000 deaths recorded in 2023.

Progress, yes, but not nearly enough. In the 12-month period ending August 2025, approximately 73,000 people still died from overdoses.

Beyond fatalities, more than 40 million Americans reported struggling with a substance use disorder in 2024.

For families searching for help, those numbers represent real people, parents, siblings, children, many of whom first encountered opioids through a legitimate prescription for pain.

How Opioid Abuse Begins with Pain Treatment

The opioid epidemic didn’t emerge from a vacuum. It grew, in large part, from a healthcare system that defaulted to opioid prescriptions as the primary answer to pain.

For decades, the American approach to pain management has been caught in a dangerous paradox. Prescribing addictive opioids to treat injury, only to create a secondary crisis of addiction.

This is particularly acute after procedures like spine surgery, where many addictions arise from high opioid use in the first days of recovery, a window when patients are vulnerable and alternatives have historically been limited or not covered by insurance.

Fentanyl’s Role in Driving Overdose Deaths

The ongoing death toll is largely driven by synthetic opioids like fentanyl. Fentanyl is estimated to be 50 to 100 times more potent than morphine, and it now contaminates the broader illicit drug supply.

This means people struggling with heroin addiction or other narcotic addiction are frequently exposed to it unknowingly.

Naloxone (brand name Narcan) remains the frontline life-saving response to opioid overdose.

It is available without a prescription at most pharmacies and through harm reduction programs.

If someone in your life is using opioids, prescribed or otherwise, having naloxone on hand can mean the difference between life and death.

What’s Driving the Change in Pain Management

President Trump’s January 2025 executive order establishing the “Great American Recovery Initiative” builds on two key federal actions, the HHS Pain Management Best Practices Inter-Agency Task Force and the bipartisan No PAIN Act.

The No PAIN Act expands and incentivizes Medicare coverage for non-opioid pain treatments in surgical settings, directly addressing the financial barrier that has historically made opioids the default, cheaper choice.

The goal, advocates say, is to prevent opioid addiction from starting in the first place, treating pain without creating the conditions for dependence.

New Non-Opioid Treatments Showing Promise

Several promising alternatives are now moving from research into real-world use. In early 2025, the FDA approved Journavx (suzetrigine), a first-in-class non-opioid oral medication that targets pain-signaling sodium channels in the peripheral nervous system rather than the brain.

It’s an approach that offers acute pain relief without the addiction risk associated with opioids.

Electrical therapies are also advancing, including closed-loop spinal cord stimulation, peripheral nerve stimulation and Basivertebral Nerve Ablation.

These systems use low-voltage electrical currents to interrupt pain signals, improving function and quality of life while reducing opioid exposure and healthcare utilization.

These technologies won’t undo existing opioid addiction, but they represent a real chance to reduce the pipeline of new cases.

Finding Help for Opioid Addiction

If you or someone you love is already struggling with opioid or narcotic addiction, treatment works, and peer support through Narcotics Anonymous is one of the most accessible entry points to recovery.

Search Narcotics.com’s directory of NA meetings to find an option near you. You can also call 800-934-1582(Sponsored) to speak with a treatment advisor today.

The Bay Area Rapid Transit system, the largest public transportation network in the region, has emerged as one of the most visible arenas of California’s opioid epidemic. As opioid overdoses mounted onboard BART, the agency began equipping officers and staff with naloxone kits.

It’s a harm reduction measure that has since become central to how the system responds to the crisis. For thousands of daily riders, encountering opioid use and its consequences has nonetheless become a routine part of the commute, and for many, a reason to stop riding altogether.

The Opioid Crisis by the Numbers

More than 19 overdoses occurred on BART property in 2023 alone, according to reporting by The San Francisco Standard. It’s a figure already on pace to surpass the overdose death count from 2022.

The crisis continued into late 2025, when two passengers suffered narcotics overdoses on separate BART trains in the East Bay within a 48-hour window. Ridership has suffered alongside public health, with CBS News reporting a measurable decline in BART passengers in 2023 driven by commuter concerns over safety and the growing frequency of opioid-related medical emergencies.

How BART Naloxone Kits Are Saving Lives

BART first introduced naloxone nasal spray, commonly known by the brand name Narcan, in May 2019. Since then, the agency has significantly expanded the program, equipping officers and frontline staff with BART naloxone kits as standard gear.

According to ABC 7 News, deployments have grown more than sixfold over three years, rising from 29 in the first year to 188 annually. By March 2024, those interventions had successfully reversed more than 400 overdoses on BART premises.

To sustain that response capacity, BART reports that all police officers now receive formal training in naloxone administration. The kits are kept in officer toolkits at all times, ensuring a reversal agent is available anywhere on the system when an overdose occurs.

The agency has also expanded its corps of Crisis Intervention Specialists, which are trained staff focused on connecting people experiencing opioid use disorder with treatment resources rather than defaulting to arrest.

Fentanyl’s Role in the Transit Crisis

Fentanyl, a synthetic opioid estimated to be roughly 50 times more potent than the effects of heroin, is the primary driver of overdose deaths across the United States and a dominant presence in the Bay Area’s drug supply. Its extreme potency means that small variations in dose can be lethal, and illicitly manufactured fentanyl is now found in a wide range of street drugs, often without the user’s knowledge.

This is precisely why rapid access to BART naloxone kits is so consequential. In a fentanyl overdose, minutes determine survival.

Youth and Families Bear a Hidden Cost

Students and young commuters who depend on BART to reach school face a particular burden. Research published in Clinical Therapeutics found that exposure to adult substance use increases the likelihood that young people will develop substance use problems and mental health conditions of their own.

These encounters can also contribute to adverse childhood experiences (ACEs), a recognized framework linking early trauma to prolonged stress and long-term psychological harm. It illustrates the lasting impact of parental opioid abuse.

Understanding Opioid Addiction and Overdose Risk

Opioids are a class of drugs that include fentanyl, heroin, oxycodone, and other prescription painkillers. They act on receptors in the brain to reduce pain but also suppress breathing, which is what makes an overdose fatal. Narcotic addiction is a chronic medical condition, not a moral failure, and it responds to evidence-based treatment including medication-assisted therapy and peer recovery programs like Narcotics Anonymous.

Naloxone is available without a prescription at most pharmacies in California. If someone is unresponsive and opioid use is suspected, call 911 and administer naloxone immediately, fentanyl overdoses may require more than one dose. Free naloxone and fentanyl test strips are available through harm reduction organizations across the Bay Area.

Find Local NA Meetings

An important part of a successful recovery is having the support of peers who understand what you’re going through. Search Narcotics.com’s directory to find local NA meetings to start receiving support today. You can also call 800-934-1582(Sponsored) for additional assistance.

For people in Virginia’s Roanoke Valley, harm reduction backpacks are helping prevent opioid overdoses.

These backpacks are designed to help individuals at risk for opioid overdose and contain naloxone, a medication that can quickly reverse an overdose in an opioid overdose emergency. 

A community-based effort, Connection to Care (C2C) is at the heart of this opioid addiction outreach work, supported early on by a 2018 seed grant from the Vibrant Virginia initiative.

The effort connects universities and communities to work together on building practical solutions for local social challenges. 

While Roanoke offers several approaches to addressing opioid addiction and substance use disorders, the Connection to Care backpacks have already impacted thousands of lives and for the better.

Discover NA Meetings in Roanoke to receive peer support to help with your recovery.

Harm Reduction Backpacks Help Prevent Opioid Overdose

So far, C2C has provided backpacks for residents who might lack access to critical resources. The backpacks include essential supplies and connect recipients to addiction recovery services. Students and local volunteers play key roles in delivering the packs to those who need them most. 

What the small seed grant from Vibrant Virginia has accomplished is a far reaching response to the opioid crisis in Virginia.

Initial efforts focused on understanding substance use disorders in the Roanoke Valley and Pulaski County and emphasized first identifying local needs and building trust with community partners. 

Vibrant Virginia first partnered with the Virginia Harm Reduction Coalition and the Bradley Free Clinic. Collaboration with both organizations helped shape the program’s approach.

Together, they developed a model centered on direct outreach in the community, which made it easier to offer practical support to individuals facing opioid addiction. 

The C2C program and its outreach has resulted in over 8,000 contacts with at-risk individuals and harm reduction services or treatment support provided to more than 4,000 folks.

The program’s focus is on offering immediate help, but there’s also emphasis on creating pathways to long term recovery.

Opioid Addiction Response Expands Across Virginia

The success of C2C’s efforts in the community led to nearly $1 million in federal funding. Those dollars allowed for expansion of services and the introduction of new initiatives.

One example is Responders for Recovery, which pairs peer recovery specialists to support individuals after opioid overdoses.

The federal funding not only allows the program to offer more services, funds also help health providers, law enforcement and community organizations coordinate together.

That means more people can get help when they need it without having to wait for resources to become available.

The Vibrant Virginia backpacks illustrate how targeted funding and team effort can produce sustainable solutions to complex public health challenges. 

Find NA Meetings and Opioid Addiction Support

Don’t let a lack of resources or tight finances prevent you from starting recovery. There are many addiction treatment services in Virginia that can assist you.

Search Narcotics.com’s directory to find local Narcotics Anonymous meetings right in your community. Call today at 800-934-1582(Sponsored) for immediate assistance.

For anyone struggling with opioid addiction today, the path to recovery just got more complicated. A major new national study confirms what many addiction medicine doctors have been seeing on the front lines for years.

Fentanyl, the synthetic opioid that now dominates the illicit drug supply, is making it significantly harder to start patients on buprenorphine, one of the most effective and accessible medications for opioid use disorder.

The findings, published in JAMA Network Open and led by researchers at Penn State College of Medicine and the University of Pittsburgh, are a wake-up call for anyone affected by the opioid epidemic.

This includes patients, families and the healthcare providers trying to help them.

The Opioid Crisis by the Numbers

The survey of 396 clinicians across the United States paints a sobering picture of where opioid addiction treatment stands right now:

Nearly 72% of clinicians reported significant challenges starting patients on buprenorphine when fentanyl was involved. Close to 62% encountered at least one case of sudden, severe withdrawal, sometimes called precipitated withdrawal, when initiating treatment.

More than half, 52.8%, reported cases where withdrawal symptoms dragged on for days rather than the expected hours. And approximately 67% said they’ve had to change their standard treatment protocols to adapt.

These aren’t just statistics. Each one represents a real person trying to get clean who hit a wall.

What’s Driving the Change

Treating opioid addiction used to follow a relatively predictable script. When heroin was the dominant drug, clinicians could confirm use through drug screening and start patients on buprenorphine at established doses and intervals with reliable results. That consistency saved lives.

Fentanyl changed the equation starting around 2017, when it began flooding the illicit opioid supply. The problem isn’t just that fentanyl is more potent — it’s how the drug behaves in the body. Fentanyl can accumulate in fat tissue, where it lingers long after a person’s last use.

When buprenorphine is introduced, it can displace fentanyl from opioid receptors and trigger intense withdrawal far more severe and prolonged than what patients experienced during the heroin era.

“Someone can get really sick or get tired of the whole process that they stop treatment,” said lead author Dr. Sarah Kawasaki of Penn State College of Medicine. “They might start using again and might overdose or die.”

That cycle of withdrawal, dropout, relapse and overdose is one of the most devastating patterns in the current opioid epidemic.

Fentanyl’s Role in the Treatment Gap

Fentanyl is now present in the vast majority of illicit opioid supply in the United States. It has also been found in counterfeit pills and other street drugs, meaning people with opioid addiction are often exposed to it even when they don’t intend to be.

Its unique pharmacology, high potency, rapid onset, and fat-soluble accumulation, means the clinical playbook written for heroin simply doesn’t apply. Clinicians surveyed in the study responded in a variety of ways.

Some dramatically lowered initial buprenorphine doses, others went higher, some added medications to manage withdrawal symptoms and others redirected patients entirely to inpatient treatment or methadone programs.

The patchwork of adaptations reflects a field working without updated, evidence-based guidelines and patients paying the price for that gap.

Understanding Opioids and Overdose Risk

Opioids are a class of drugs, both prescription medications and illicit substances like heroin and fentanyl, that bind to receptors in the brain and body to reduce pain and produce euphoria.

Fentanyl is a synthetic opioid estimated to be 50 to 100 times more potent than morphine, making even a tiny amount potentially lethal. Opioid overdose occurs when the drug suppresses breathing to the point of oxygen deprivation; naloxone (Narcan) can reverse an overdose if administered quickly enough.

Harm Reduction and Treatment Options

Despite the challenges, researchers are emphatic that buprenorphine still works, and it remains one of the most accessible opioid addiction treatments available.

Unlike methadone, which can only be dispensed through approximately 2,000 licensed clinics nationwide, buprenorphine can be prescribed by qualified providers and filled at more than 70,000 pharmacies across the country.

If you or someone you love is struggling with opioid addiction, harm reduction steps include:

1. Carry naloxone (Narcan): Available without a prescription at many pharmacies and through community harm reduction programs. It can reverse an opioid overdose and save a life.
2. Use fentanyl test strips: These low-cost tools can detect fentanyl in a drug supply before use.
3. Talk to a doctor about medication-assisted treatment: Buprenorphine and methadone are both evidence-based options for opioid use disorder.
4. Connect with peer support: Narcotics Anonymous (NA) meetings provide community, accountability, and lived experience that clinical treatment alone can’t offer.

Finding Help for Opioid Addiction

NA Meetings Near You Narcotics Anonymous offers free peer support meetings in thousands of locations. Search for NA meetings in your city or state to find in-person and virtual options near you.

Opioid Treatment Programs Ask your primary care provider about buprenorphine, or search SAMHSA’s treatment locator at findtreatment.gov for opioid treatment programs near you.

Call for Help: SAMHSA’s National Helpline (1-800-662-4357) is free, confidential and available 24/7 for opioid addiction treatment referrals.

Harm Reduction Callout: Naloxone saves lives. If someone in your life uses opioids, or if you do, having naloxone on hand is one of the most important steps you can take. Many local health departments and harm reduction organizations distribute it for free.